Annette Frost

1.7k total citations
29 papers, 1.4k citations indexed

About

Annette Frost is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Annette Frost has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Cell Biology. Recurrent topics in Annette Frost's work include Microtubule and mitosis dynamics (8 papers), Cancer Treatment and Pharmacology (7 papers) and MRI in cancer diagnosis (5 papers). Annette Frost is often cited by papers focused on Microtubule and mitosis dynamics (8 papers), Cancer Treatment and Pharmacology (7 papers) and MRI in cancer diagnosis (5 papers). Annette Frost collaborates with scholars based in Germany, United States and Switzerland. Annette Frost's co-authors include K. Mross, Martin Büchert, Simone Steinbild, Clemens Unger, Susanne Hedbom, Roland Heinig, Oliver Boix, Ulrike Fasol, R. Kaiser and M. E. Scheulen and has published in prestigious journals such as Journal of Clinical Oncology, Gut and Clinical Cancer Research.

In The Last Decade

Annette Frost

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annette Frost Germany	14	747	493	462	226	207	29	1.4k
Tae-You Kim South Korea	24	689 0.9×	420 0.9×	678 1.5×	299 1.3×	74 0.4×	48	1.5k
S. Gail Eckhardt United States	14	779 1.0×	470 1.0×	686 1.5×	179 0.8×	102 0.5×	46	1.3k
Raija Ristamäki Finland	21	760 1.0×	230 0.5×	535 1.2×	226 1.0×	56 0.3×	52	1.3k
Haitian Quan China	17	662 0.9×	383 0.8×	492 1.1×	136 0.6×	111 0.5×	30	1.3k
Fawn Qian United States	4	629 0.8×	481 1.0×	685 1.5×	266 1.2×	359 1.7×	4	1.6k
Jean Mendiboure France	12	945 1.3×	412 0.8×	410 0.9×	182 0.8×	95 0.5×	17	1.6k
Simone Steinbild Germany	12	488 0.7×	263 0.5×	353 0.8×	81 0.4×	112 0.5×	19	863
Yiyi Yu China	21	741 1.0×	460 0.9×	447 1.0×	152 0.7×	253 1.2×	99	1.4k
N. Schleucher Germany	19	802 1.1×	610 1.2×	598 1.3×	173 0.8×	172 0.8×	32	1.6k
Henry Xiong United States	11	769 1.0×	303 0.6×	342 0.7×	71 0.3×	157 0.8×	20	1.1k

Countries citing papers authored by Annette Frost

Since Specialization

Citations

This map shows the geographic impact of Annette Frost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Frost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Frost more than expected).

Fields of papers citing papers by Annette Frost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Frost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Frost. The network helps show where Annette Frost may publish in the future.

Co-authorship network of co-authors of Annette Frost

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Frost. A scholar is included among the top collaborators of Annette Frost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Frost. Annette Frost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mross, K., Heike Richly, Annette Frost, et al.. (2016). A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 78(2). 405–417. 14 indexed citations

Mross, K., Martin Büchert, Annette Frost, et al.. (2014). Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. BMC Cancer. 14(1). 510–510. 26 indexed citations

Mross, K., Annette Frost, Simone Steinbild, et al.. (2012). A Phase I Dose–Escalation Study of Regorafenib (BAY 73–4506), an Inhibitor of Oncogenic, Angiogenic, and Stromal Kinases, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 18(9). 2658–2667. 262 indexed citations

Frost, Annette, K. Mross, Simone Steinbild, et al.. (2012). Phase I Study of the Plk1 Inhibitor BI 2536 Administered Intravenously on Three Consecutive Days in Advanced Solid Tumours. Current Oncology. 19(1). 28–35. 62 indexed citations

Strumberg, Dirk, M. E. Scheulen, Beate Schultheis, et al.. (2012). Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study. British Journal of Cancer. 106(11). 1722–1727. 204 indexed citations

Fasol, Ulrike, Annette Frost, Martin Büchert, et al.. (2011). Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis. Annals of Oncology. 23(4). 1030–1036. 79 indexed citations

Mross, K., Annette Frost, M. E. Scheulen, et al.. (2011). Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer. PubMed. 3(1). 16–16. 10 indexed citations

Antonarakis, Emmanuel S., Elisabeth I. Heath, David C. Smith, et al.. (2011). A noncomparative randomized phase II study of two dose levels of itraconazole in men with metastatic castration-resistant prostate cancer (mCRPC): A DOD/PCCTC trial.. Journal of Clinical Oncology. 29(15_suppl). 4532–4532. 4 indexed citations

Scheulen, M. E., K. Mross, Heike Richly, et al.. (2010). A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered days 1 and 15, every four weeks in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). e13065–e13065. 6 indexed citations

10.

Mross, K., M. E. Scheulen, Annette Frost, et al.. (2010). A phase I dose-escalation study of BI 811283, an Aurora B inhibitor, administered every three weeks in patients with advanced solid tumors.. Journal of Clinical Oncology. 28(15_suppl). 3011–3011. 9 indexed citations

11.

Steinbild, Simone, Annette Frost, Brian Z. Ring, Clemens Unger, & K. Mross. (2009). Phase II Study with 3rd- or 4th-Line Bendamustine (Flat Dose) Therapy in Patients with Metastatic Breast Cancer. Onkologie. 32(8-9). 488–492. 1 indexed citations

12.

Mross, K., Ulrike Fasol, Annette Frost, et al.. (2009). DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study. PubMed. 1(1). 5–5. 41 indexed citations

13.

Frost, Annette, Martin Buechert, Clemens Unger, et al.. (2008). Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced solid tumors: Final results of a dose-escalation study. Journal of Clinical Oncology. 26(15_suppl). 2558–2558. 8 indexed citations

14.

Steinbild, Simone, J. Arends, Michael Medinger, et al.. (2007). Metronomic Antiangiogenic Therapy with Capecitabine and Celecoxib in Advanced Tumor Patients – Results of a Phase II Study. Oncology Research and Treatment. 30(12). 629–635. 34 indexed citations

15.

Steinbild, Simone, Annette Frost, R. Morant, et al.. (2007). A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV. British Journal of Cancer. 97(11). 1480–1485. 80 indexed citations

16.

Mross, K., Norbert Holländer, Annette Frost, et al.. (2006). PAC Fixed Dose: Pharmacokinetics of a 1-Hour Paclitaxel Infusion and Comparison to BSA-Normalized Drug Dosing. Oncology Research and Treatment. 29(10). 444–450. 6 indexed citations

17.

Frost, Annette, et al.. (2006). Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience. Oncology Research and Treatment. 29(7). 314–318. 13 indexed citations

18.

Munzert, Gerd, Simone Steinbild, Annette Frost, et al.. (2006). A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors. Journal of Clinical Oncology. 24(18_suppl). 3069–3069. 13 indexed citations

19.

Mross, K., Annette Frost, Ralph Strecker, et al.. (2005). A clinical phase I, pharmacokinetic (PK), and pharmacodynamic study of twice daily BIBF 1120 in advanced cancer patients. Journal of Clinical Oncology. 23(16_suppl). 3031–3031. 19 indexed citations

20.

Sarre, R. G., Annette Frost, David G. Jagelman, et al.. (1987). Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps.. Gut. 28(3). 306–314. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact